450 related articles for article (PubMed ID: 15728483)
41. CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis.
Morimoto J; Yoneyama H; Shimada A; Shigihara T; Yamada S; Oikawa Y; Matsushima K; Saruta T; Narumi S
J Immunol; 2004 Dec; 173(11):7017-24. PubMed ID: 15557199
[TBL] [Abstract][Full Text] [Related]
42. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
[TBL] [Abstract][Full Text] [Related]
43. Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice.
Oikawa Y; Shimada A; Kasuga A; Morimoto J; Osaki T; Tahara H; Miyazaki T; Tashiro F; Yamato E; Miyazaki J; Saruta T
J Immunol; 2003 Dec; 171(11):5865-75. PubMed ID: 14634096
[TBL] [Abstract][Full Text] [Related]
44. Emergence of a broad repertoire of GAD65-specific T-cells in type 1 diabetes patients with graft dysfunction after allogeneic islet transplantation.
Chujo D; Foucat E; Takita M; Itoh T; Sugimoto K; Shimoda M; Yagi K; Yamagishi M; Tamura Y; Yu L; Naziruddin B; Levy MF; Ueno H; Matsumoto S
Cell Transplant; 2012; 21(12):2783-95. PubMed ID: 22963904
[TBL] [Abstract][Full Text] [Related]
45. Diabetogenic T-cell clones.
Haskins K; Wegmann D
Diabetes; 1996 Oct; 45(10):1299-305. PubMed ID: 8826963
[TBL] [Abstract][Full Text] [Related]
46. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV
J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087
[TBL] [Abstract][Full Text] [Related]
47. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
[TBL] [Abstract][Full Text] [Related]
48. Importance of GAD65 peptides and I-Ag7 in the development of insulitis in nonobese diabetic mice.
Ogino T; Sato K; Miyokawa N; Kimura S; Katagiri M
Immunogenetics; 2000 Jun; 51(7):538-45. PubMed ID: 10912505
[TBL] [Abstract][Full Text] [Related]
49. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes.
Scott GS; Fishman S; Khai Siew L; Margalit A; Chapman S; Chervonsky AV; Wen L; Gross G; Wong FS
J Autoimmun; 2010 Dec; 35(4):390-7. PubMed ID: 20850948
[TBL] [Abstract][Full Text] [Related]
50. Autoimmune islet damage mediated by insulin-specific T cells.
Crawford M; Daniel D; Wegmann D; Yang H; Gill RG
Transplant Proc; 1997; 29(1-2):758-9. PubMed ID: 9123512
[No Abstract] [Full Text] [Related]
51. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543).
Overbergh L; Decallonne B; Waer M; Rutgeerts O; Valckx D; Casteels KM; Laureys J; Bouillon R; Mathieu C
Diabetes; 2000 Aug; 49(8):1301-7. PubMed ID: 10923629
[TBL] [Abstract][Full Text] [Related]
52. Local autoantigen expression as essential gatekeeper of memory T-cell recruitment to islet grafts in diabetic hosts.
Alkemade GM; Clemente-Casares X; Yu Z; Xu BY; Wang J; Tsai S; Wright JR; Roep BO; Santamaria P
Diabetes; 2013 Mar; 62(3):905-11. PubMed ID: 23160528
[TBL] [Abstract][Full Text] [Related]
53. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.
Wong FS; Karttunen J; Dumont C; Wen L; Visintin I; Pilip IM; Shastri N; Pamer EG; Janeway CA
Nat Med; 1999 Sep; 5(9):1026-31. PubMed ID: 10470079
[TBL] [Abstract][Full Text] [Related]
54. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.
Daniel D; Gill RG; Schloot N; Wegmann D
Eur J Immunol; 1995 Apr; 25(4):1056-62. PubMed ID: 7537670
[TBL] [Abstract][Full Text] [Related]
55. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes.
Holz A; Dyrberg T; Hagopian W; Homann D; von Herrath M; Oldstone MB
J Immunol; 2000 Nov; 165(10):5945-53. PubMed ID: 11067957
[TBL] [Abstract][Full Text] [Related]
56. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.
Augstein P; Dunger A; Heinke P; Wachlin G; Berg S; Hehmke B; Salzsieder E
Biochem Biophys Res Commun; 2003 May; 304(2):378-84. PubMed ID: 12711326
[TBL] [Abstract][Full Text] [Related]
57. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells.
Peterson JD; Haskins K
Diabetes; 1996 Mar; 45(3):328-36. PubMed ID: 8593938
[TBL] [Abstract][Full Text] [Related]
58. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
Pankewycz O; Strom TB; Rubin-Kelley VE
Eur J Immunol; 1991 Apr; 21(4):873-9. PubMed ID: 1902177
[TBL] [Abstract][Full Text] [Related]
59. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
[TBL] [Abstract][Full Text] [Related]
60. GAD65 and insulin B chain peptide (9-23) are not primary autoantigens in the type 1 diabetes syndrome of the BB rat.
Bieg S; Hanlon C; Hampe CS; Benjamin D; Mahoney CP
Autoimmunity; 1999; 31(1):15-24. PubMed ID: 10593565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
